ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation.

Xiang-Yu Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.